Patents by Inventor Peter A. Cerutti

Peter A. Cerutti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6337182
    Abstract: Method for the Quantitative Determination of DNA Sequences A method for the quantitative determination of DNA sequences containing at least one mutationally eliminated restriction site is disclosed in which the DNA sequences to be quantitatively determined are selectively amplified continuously eliminating any residual wild-type DNA sequences.
    Type: Grant
    Filed: June 6, 1991
    Date of Patent: January 8, 2002
    Assignee: Dade Behring Marburg GmbH
    Inventors: Peter A. Cerutti, Emanuela Felley-Bosco, Martha Sandy, Paul Amstad, Jacob Zijlstra, Charareh Pourzand
  • Patent number: 5750334
    Abstract: The invention relates to the direct detection of human papillomavirus MRNA and DNA. The recently developed polymerase chain reaction was modified in order to improve the sensitivity and specificity. By choosing appropriate oligonucleotide primers (amplimers) and reaction temperatures, individual HPV genes from among the total cell DNA can be identified and amplified to an extent such that non-isotopic detection is possible. In addition, use of reverse transcription permits selective amplification of spliced mRNA and thus permits indication of premalignant or malignant conditions and/or lesions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 12, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Peter Cerutti, Jeannette Whitcomb, Jacob Zijlstra, Ethel-Michelle de Villiers
  • Patent number: 5187060
    Abstract: It was possible to increase substantially the sensitivity of detection of influenza A virus by carrying out a polymerase chain reaction (PCR), using oligonucleotide sequences (amplimers) from the relatively conserved region of the viral hemagglutinin gene, preceded by reverse transcription (RT). The reverse transcription and the PCR are insensitive to single mutations by base exchange in this case, as long as the 3' end of the amplimer is not affected.
    Type: Grant
    Filed: August 31, 1990
    Date of Patent: February 16, 1993
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Peter A. Cerutti, Alberic Bressoud